These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3492906)
1. Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias. Roy D; Montigny M; Klein GJ; Sharma AD; Cassidy D Am J Cardiol; 1987 Jan; 59(1):89-92. PubMed ID: 3492906 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Rowland E; McKenna WJ; Krikler DM Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil]. Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987 [TBL] [Abstract][Full Text] [Related]
4. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing. Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516 [TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic and antiarrhythmic properties of bepridil. Prystowsky EN Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M; Steinbeck G; Lüderitz B Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of bepridil efficacy by electrophysiologic testing in patients with recurrent ventricular tachycardia: comparison of two regimens. Brembilla-Perrot B; Aliot E; Clementy J; Cosnay P; Djiane P; Fauchier JP; Kacet S; Lellouche D; Mabo P; Richard M Cardiovasc Drugs Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1390333 [TBL] [Abstract][Full Text] [Related]
8. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study]. Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia. Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627 [TBL] [Abstract][Full Text] [Related]
10. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias. Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280 [TBL] [Abstract][Full Text] [Related]
12. Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia. Reddy CP; McAllister RG Am J Cardiol; 1984 Sep; 54(6):535-43. PubMed ID: 6475770 [TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effect of sotalol in supraventricular tachycardias]. Borggrefe M; Breithardt G Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828 [TBL] [Abstract][Full Text] [Related]
14. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect]. Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053 [TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia]. Manz M; Beermann J; Gerckens U; Lüderitz B Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226 [TBL] [Abstract][Full Text] [Related]
16. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate. Kim SS; Lal R; Ruffy R Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336 [TBL] [Abstract][Full Text] [Related]
17. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia]. Pfitzner P; Manz M; Schütz R; Lüderitz B Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias. Ho RT; Frisch DR; Pavri BB; Levi SA; Greenspon AJ Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):597-605. PubMed ID: 23629734 [TBL] [Abstract][Full Text] [Related]
19. Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction. Derval N; Skanes AC; Gula LJ; Gray C; Denis A; Lim HS; Krahn AD; Yee R; Sacher F; Haïssaguerre M; Klein GJ Heart Rhythm; 2013 Dec; 10(12):1785-91. PubMed ID: 24076446 [TBL] [Abstract][Full Text] [Related]
20. Differences in ventriculoatrial intervals during entrainment and tachycardia: a simpler method for distinguishing paroxysmal supraventricular tachycardia with long ventriculoatrial intervals. González-Torrecilla E; Almendral J; García-Fernández FJ; Arias MA; Arenal A; Atienza F; Datino T; Atea LF; Calvo D; Pachón M; Fernández-Avilés F J Cardiovasc Electrophysiol; 2011 Aug; 22(8):915-21. PubMed ID: 21385264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]